biopharma-reporter1d
Umoja raises $100 million to boost its CAR-T cell gene therapy pipeline
The oversubscribed Series C financing round will support the clinical development of in vivo CAR-T cells for oncology and ...
biopharma-reporter1d
Hinge Bio raises $30 million to progress B cell lupus therapy
The US biotech aims to bring its antibody-based therapies to human trials later in the year and to develop new candidate ...
biopharma-reporter3d
Windward Bio launches to develop potential best-in-class antibody against asthma and COPD
The Swiss drug development company Windward Bio recently announced that it had officially launched with a $200 million Series ...
biopharma-reporter3d
Regenxbio and Nippon Shinyaku collaborate to develop and commercialize gene therapies for Mucopolysaccharidosis I and II
The US gene therapy company Regenxbio and the Japanese firm Nippon Shinyaku have joined forces to boost the development and commercialization of Regenxbio’s gene therapies RGX-121 for the treatment of ...